Journal of drug targeting, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 19

Published: March 10, 2025

Esophageal cancer (EC) is among the most common illnesses globally, and its prognosis unfavorable. Surgery, radiotherapy, chemotherapy are primary therapy options for EC. Despite occasional efficacy of these traditional treatment modalities, individuals with EC remain at a significant risk local recurrence metastasis. Consequently, innovative efficacious medicines required. In recent decades, clinical practice has effectively implemented cell therapy, which includes both stem non-stem cell-based approaches, as an tumor treatment, offering renewed hope to patients esophageal squamous carcinoma (ESCC). This paper examines theoretical framework contemporary advancements in We further described current studies summarized essential data related survival safety assessments.

Language: Английский